Risk factors for neovascular glaucoma after vitrectomy in eyes with proliferative diabetic retinopathy

Código QR

Risk factors for neovascular glaucoma after vitrectomy in eyes with proliferative diabetic retinopathy

Masashi Sakamoto, Ryuya Hashimoto, Izumi Yoshida, Makoto Ubuka, Takatoshi Maeno Department of Ophthalmology, Toho University Sakura Medical Center, Shimoshizu, Sakura, Japan Purpose: To investigate the potential risk factors for neovascular glaucoma (NVG) after vitrectomy in eyes with proliferativ...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Sakamoto M, Hashimoto R, Yoshida I, Ubuka M, Maeno T
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2018
Materias:	neovascular glaucoma proliferative diabetic retinopathy vitrectomy Ophthalmology RE1-994
Acceso en línea:	https://doaj.org/article/c4984bd3fd644016a45cdd658850efc4
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Risk factors for requirement of filtration surgery after vitrectomy in patients with proliferative diabetic retinopathy
por: Sakamoto M, et al.
Publicado: (2018)

Is Chronic Kidney Disease Affecting the Postoperative Complications of Vitrectomy for Proliferative Diabetic Retinopathy?
por: Yusuke Kameda, et al.
Publicado: (2021)

Differential association of elevated inflammatory cytokines with postoperative fibrous proliferation and neovascularization after unsuccessful vitrectomy in eyes with proliferative diabetic retinopathy
por: Yoshida S, et al.
Publicado: (2017)

EXPERIENCE OF SURGICAL TREATMENT OF PROLIFERATIVE DIABETIC RETINOPATHY
por: O. M. Trubina, et al.
Publicado: (2016)

Optical Coherence Tomography Angiography Features of Neovascularization in Proliferative Diabetic Retinopathy
por: Vaz-Pereira S, et al.
Publicado: (2020)

Features of proliferative process in patients with diabetic retinopathy
por: Dmitriy Valentinovich Lipatov, et al.
Publicado: (2012)

Timing of neovascular regression in eyes with high-risk proliferative diabetic retinopathy without macular edema treated initially with intravitreous bevacizumab
por: Shakarchi FI, et al.
Publicado: (2018)

Evaluation of Retinal Detachment After Diabetic Vitrectomy: Causes and Ways of Management
por: Abdelhadi AM, et al.
Publicado: (2020)

Neovascular glaucoma in patients with diabetes mellitus — the current state of the problem
por: V. A. Biletskaya, et al.
Publicado: (2021)

Pars Plana Vitrectomy for Full-Thickness Macular Holes in Patients with Proliferative Diabetic Retinopathy and Active Fibrovascular Proliferation
por: Karimov M, et al.
Publicado: (2020)

Subthreshold microsecond laser for proliferative diabetic retinopathy: a randomized pilot study
por: Jhingan M, et al.
Publicado: (2018)

Visual evoked potentials after panretinal photocoagulation in patients with proliferative diabetic retinopathy
por: Amini Vishte R, et al.
Publicado: (2019)

Vitreous concentrations of vascular endothelial growth factor as a potential biomarker for postoperative complications following pars plana vitrectomy
por: Faruk Nisic, et al.
Publicado: (2019)

The efficacy of Alahmady ring implantation in the management of neovascular glaucoma
por: Alsmman AH, et al.
Publicado: (2017)

Natural History of Diabetic Retinopathy Through Retrospective Analysis in Type 2 Diabetic Patients—An Exploratory Study
por: Mehak Gupta, et al.
Publicado: (2021)

LOCAL AND SYSTEMIC VEGF-А PRODUCTION IN COMPLICATED PROLIFERATIVE DIABETIC RETINOPATHY
por: V. V. Neroev, et al.
Publicado: (2016)

Value of optical coherence tomography in the detection of macular pathology before the removal of silicone oil
por: Rashad MA, et al.
Publicado: (2016)

Glaucoma drainage device implantation with adjunctive intravitreal bevacizumab in neovascular glaucoma: 3-year experience
por: Noor NA, et al.
Publicado: (2017)

Intraocular pressure 1 year after vitrectomy in eyes without a history of glaucoma or ocular hypertension
por: Fang Y, et al.
Publicado: (2017)

Baerveldt or Ahmed glaucoma valve implantation with pars plana tube insertion in Japanese eyes with neovascular glaucoma: 1-year outcomes
por: Suda M, et al.
Publicado: (2018)

INTRAVITREAL INTRODUCTION OF LUCENTIS AND TRANS-SCLERAL CYCLOPHOTOCOAGULATION IN THE TREATMENT OF NEOVASCULAR GLAUCOMA IN DIABETES MELLITUS
por: V. P. Fokin, et al.
Publicado: (2016)

Randomized comparative trial of diode laser transscleral cyclophotocoagulation versus Ahmed glaucoma valve for neovascular glaucoma in Chinese – a pilot study
por: Choy BN, et al.
Publicado: (2018)

Pars Plana Vitrectomy Reoperations for Complications of Proliferative Diabetic Retinopathy
por: Al-khersan H, et al.
Publicado: (2020)

The Evolving Treatment of Diabetic Retinopathy
por: Mansour SE, et al.
Publicado: (2020)

Macular edema in siliconized eyes
por: Kaya A, et al.
Publicado: (2016)

Evaluation of effectiveness of contact transscleral diode laser cyclocoagulation drainage after neovascular glaucoma surgery
por: Dmitry V. Lipatov, et al.
Publicado: (2017)

Vitreous and Serum Concentrations of Vascular Endothelial Growth Factor and Platelet-Derived Growth Factor in Proliferative Diabetic Retinopathy
por: Muhiddin HS, et al.
Publicado: (2020)

White Matter Hyperintensities of Bilateral Lenticular Putamen in Patients with Proliferative Diabetic Retinopathy: A Voxel‐based Morphometric Study
por: Xiao A, et al.
Publicado: (2021)

The Appropriateness of Digital Diabetic Retinopathy Screening Images for a Computer-Aided Glaucoma Screening System
por: Almazroa AA, et al.
Publicado: (2020)

Metabolism in Retinopathy of Prematurity
por: Yohei Tomita, et al.
Publicado: (2021)

Short-term outcomes after EX-PRESS implantation versus trabeculectomy alone in patients with neovascular glaucoma
por: Shinohara Y, et al.
Publicado: (2017)

Preoperative intravitreal Ranibizumab with panretinal photocoagulation followed by conventional trabeculectomy without drainage device for neovascular glaucoma
por: Xiao-Dong Han, et al.
Publicado: (2021)

Segmentation and removal of fibrovascular membranes with high-speed 23 G transconjunctival sutureless vitrectomy, in severe proliferative diabetic retinopathy
por: Celik E, et al.
Publicado: (2016)

A Review of Advancements and Evidence Gaps in Diabetic Retinopathy Screening Models
por: Pearce E, et al.
Publicado: (2020)

Successful Treatment of Peripheral Proliferative Vitreoretinopathy with Cryocoagulation During Retinal Detachment Repair – A New Surgical Technique
por: Lang C, et al.
Publicado: (2020)

Efficacy and Safety of Various Treatments for Proliferative Diabetic Retinopathy: A Systematic Review and Network Meta-Analysis
por: Bo Zhang, et al.
Publicado: (2021)

Risk factors for requirement of filtration surgery after vitrectomy in patients with proliferative diabetic retinopathy [Corrigendum]
por: Sakamoto M, et al.
Publicado: (2018)

Cyanidin-3-o-glucoside (C3G) inhibits vascular leakage regulated by microglial activation in early diabetic retinopathy and neovascularization in advanced diabetic retinopathy
por: Fangling Zhao, et al.
Publicado: (2021)

Comparison of outcomes: scleral buckling and pars plana vitrectomy versus vitrectomy alone for primary repair of rhegmatogenous retinal detachment
por: Lindsell LB, et al.
Publicado: (2016)

The outcomes and prognostic factors of vitrectomy in chronic diabetic traction macular detachment
por: Abunajma MA, et al.
Publicado: (2016)